nanoparticles was 90% and the cumulative drug release was 94% over 16 days, with a 20% burst release in the first 24 hours. 
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Introduction
Disorders affecting the posterior segment of the eye, which cause visual impairment and blindness, are occurring at an increasing rate [1] . For example, it has been estimated that within a few years ca. 30 million Americans will be affected by age-related macular degeneration (AMD). Injection of drugs into the vitreous cavity (intravitreal injection) delivers therapeutics to the target site, however, when the disease is chronic, such as with uveitis, macular edema and AMD, frequent injections are required to achieve intraocular drug levels within the therapeutic range. This can cause severe secondary effects such as cataracts, retinal detachment, endophthalmitis and intravitreal haemorrhages. Even though intravitreal injection is accepted clinically, patient compliance is poor and the risk of complications increases dramatically as the number of required injections increases with the age of the patient. An effective drug delivery platform is required to solve this problem.
Currently, micro-and nanoparticles prepared from linear, biodegradable polyesters such as poly(lactic-co-glycolic acid) (PLGA) are used as intraocular drug delivery systems. [2] However, polymer degradation produces acidic species that can cause inflammation. In addition, chemical functionalisation of the particle surface is non-trivial and drug release cannot be triggered. Self-assembling peptide-based materials have a number of attractive features in the context of nanoparticles for drug delivery [3] : their biodegradation produces non-inflammatory amino acids; rich chemical diversity allows easy attachment of, inter alia, targeting vectors and species to improve biocompatibility; self-assembly in aqueous media is compatible with the loading of sensitive cargoes such as growth factors, proteins, biopharmaceuticals and nucleotides.
An efficient method for preparing self-assembling polypeptides is by the polymerisation of Ncarboxyanhydride (NCA) derivatives of a-amino acids [3] [4] [5] . Controlled polymerisation of NCAs to produce well-defined polypeptides of desired molecular weight and narrow dispersity can be achieved using a variety of species including primary amines [6] , certain transition metal complexes [7, 8] and N-trimethylsilylamines [9, 10] . When using primary amines as initiators, a number of strategies to improve polymerisation control, including lower reaction temperatures [11, 12] , the use of ammonium salts as dormant initiators [13, 14] and the removal of CO 2 by purging the reaction vessel with inert gas [15] , have been employed. In our work, we use TMS-amines developed by Cheng et al. [9, 10] as initiators, since polymerisations are generally more rapid and give better control than when primary amines are used. Here we report the preparation of nanoparticles from block copolymers of poly(L-glutamic acid) and poly(ε-carbobenzyloxy-L-lysine), synthesised by sequential NCA polymerization of benzyl-L-glutamate (BnE) and Z-lysine (ZK) NCAs, followed by deprotection of the benzyl-Lglutamate block (Figure 1) . We chose to deprotect the BnE rather than the ZK block since poly(L-lysine) is known to be cytotoxic. Poly(glutamic acid-b-lysine) block copolymers have been prepared previously from NCA polymerization by Lecommandoux et al. and were shown to assemble into a variety of nanostructures [16, 17] , but only at low (<4) or high (>10) pH values which are not suitable for drug delivery applications. After this time the reaction mixture was allowed to cool down to room temperature. The reaction mixture was added to ice-cold (-18 °C) hexane (60 mL) and the precipitate recrystallized twice from THF/hexane at -18 °C. The white solid was obtained by centrifugation following each crystallization, and finally dried under high vacuum overnight to afford BnE NCA (1.62 g; 73% yield) as a white powder. 
Synthesis of ε-Carbobenzyloxy-L-Lysine (ZK) NCA
To a stirred suspension of H-Lys(Z)-OH (2.00 g, 7.13 mmol) in 20 mL of anhydrous THF under an atmosphere of nitrogen at 50 °C was added triphosgene (0.71 g, 2.38 mmol) in one portion and stirred to dissolution. The reaction was stirred under a flow of nitrogen for 3 h at 50 °C. When solid starting material remained after one hour, an aliquot (0.05 equiv.) of triphosgene was added and this was repeated every half an hour if there was still solid left.
After this time the reaction mixture was allowed to cool down to room temperature. The reaction mixture was added to ice-cold (-18 °C) hexane (60 mL) and the precipitate recrystallized twice from THF/hexane at -18 °C. 
Synthesis of Poly(γ-benzyl-L-glutamic acid) (PBnE)
γ-Benzyl-protected L-glutamic acid NCA (0.5 g, 1.89 mmol) was dissolved in anhydrous DMF (10 ml). A Schlenk tube was preflushed with nitrogen gas before the dissolved NCA compound was added. N-Benzylamine TMS (0.038 mmol) was added dropwise to the Schlenk tube. The reaction was stirred for 24 hours at room temperature. To stop the reaction, the solution was added dropwise to diethyl ether (190 ml). The product was stored overnight at -8 ˚C for precipitation. After complete precipitation the sample was centrifuged to obtain a white solid. Further purification was carried out by re-dissolving in THF following by precipitation in 20-fold excess of diethyl ether. The purification was repeated one further time. The final pure product was dried under high vaccum overnight to obtain a white powder (0.551 g, 66% yield Following this a 30 µL sample was withdrawn and diluted to give a 1 mg/mL solution for GPC analysis. ZK NCA (137 mg, 0.38 mmol) was dissolved in 1.5 mL of dry DMF, and via syringe added to the reaction mixture. After 24 h of additional stirring a 30 µL sample was withdrawn and diluted to give a 1 mg/mL solution for GPC analysis and the remainder of the reaction was poured into a 20-fold excess of diethyl ether with stirring. The precipitated solid was collected by centrifugation. Further purification was achieved by re-dissolving in THF and precipitating into a 20-fold excess of diethyl ether to afford the block copolypeptide (yield 184 mg, 91%) as a white powder. 1 The block copolymers were dissolved in THF (0.025 g ml -1 ). 
Self-assembly
The polymers were first dissolved in THF at a concentration of 1.0 mg ml -1 . Filtered MilliQ water was added to the solution and it was stirred overnight, allowing the THF to evaporate. If necessary, the solutions were finally filtered through a 0.45 µm filter. The final polymer concentration in water was 1.0 mg ml -1 . Polymers were dissolved in a solution of 0.02 mg ml -1 of Nile Red in THF resulting in a dissolved polymer concentration of 1.0 mg ml -1 . After successful dissolution, filtered MilliQ water was added and it was stirred overnight to allow the THF to evaporate. The final polymer concentration in water was 1.0 mg ml -1 .
Nile Red encapsulation
Dexamethasone Encapsulation and Release
The nanoparticles loaded with dexamethasone (DX) were prepared following this procedure:
10 mg of the polymer were dissolved in 5 ml solution of 0.1 mg ml -1 DX in THF and 5 ml The mobile phase flow was set at 1 ml min -1 and the injection volume was 150 µl. After equilibration with the solvent to obtain a stable baseline, aliquots of samples were injected.
The absorbance of the eluent was monitored at 254 nm with a detection sensitivity of 0.10 aufs. All analyses were performed at 25ºC.
For analysis of DX encapsulation efficiency, stock solutions of DX were prepared by dissolving 5 mg of DX in 25 ml in DCM:ACN (2:8) (0.2 mg ml -1 ). Solutions were protected from exposure to light. The resulting solutions were then diluted with DCM:ACN (2:8) to
give drug concentrations of 2 µg ml -1 , 5 µg ml -1 , 10 µg ml -1 , 15 µg ml -1 and 20 µg ml -1 . For analysis of DX release, stock solutions of DX were prepared by dissolving 5 mg of DX in 25 ml of PBS (0.2 mg ml -1 ). Solutions were protected from exposure to light. The resulting solutions were then diluted with PBS to give drug concentrations of 2 µg ml -1 , 5 µg ml -1 , 10 µg ml -1 , 15 µg ml -1 and 20 µg ml -1 . The assay was validated with respect to linearity, accuracy and reliability in the range of concentrations of 2-20 µg ml -1 .
Encapsulation efficiency was calculated via following equation:
Actual drug loading Drug encapsulation efficiency (%, w/w)= 100 Theoretical drug loading ×
The drug loading of drug was calculated by the following equation:
Actual drug loading Drug loading (%, w/w)= 100 overall mass of NPs ×
Results and Discussion
For the synthesis of amphiphilic polymers, a hydrophilic and a hydrophobic monomer is required. We decided to use γ-benzyl-protected L-glutamic acid (BnE) and ε-(benzyloxycarbonyl)-L-lysine (ZK) as the parent amino acids. Although these monomers will initially form hydrophobic diblock copolymers, either amino acid can be deprotected to produce an amphiphilic block copolymer product. Triphosgene is the most widely used compound to create N-carboxyanhydride (NCA) derivatives for ring-opening polymerisation (ROP). In this work, the procedure according to Daly and co-workers was followed [18] . After two hours reaction time in THF, full conversion of the amino acids into NCAs was observed.
All reaction mixtures became clear solutions and the products were recrystallized several times to remove the by-product, HCl. As a consequence, yields of these NCAs were high using the exact conditions as described by Daly and co-workers.
Homopolymerization of BnE NCA was carried out using TMS-protected benzylamine as initiator, giving a high degree of control over the reaction. The predicted number average molecular weight (M n ) agrees very well with the observed value and the low dispersity value (Ɖ M = 1.15) indicates a controlled polymerization (Table 1) . Therefore, block copolymerizations were also carried out using this initiator. It was found that isolation and purification of the first BnE block before attempting chain extension with ZK NCA did not lead to well-defined block copolymers (data not shown). Consequently, the ZK NCA was added directly to the reaction medium after complete consumption of the BnE NCA. In this manner, block copolypeptides with either a 1:1 or 2:1 target block ratio between BnE and ZK were synthesized successfully. Before the addition of ZK NCA a small sample was removed for GPC analysis, to investigate the control of the polymerization of the first block.
Determination of the poly-Z-protected lysine (PZK) block length was carried out by NMRpeak integration measurements. All block copolymers showed good to excellent control over the polymerization. The Ɖ M values ranged from 1.12 to 1.28 for polymers with a ratio of 2:1 and the polymer with a ratio of 1:1 showed a low PDI of 1.27. determined by GPC using DMF as eluent; c) M n of first block determined by GPC (THF eluent); total M n estimated by GPC and 1 H NMR spectroscopy.
Block copolypeptide products were converted into amphiphilic polypeptides by hydrolysis of the benzyl protecting group on the glutamate block. This strategy was favoured over the alternative lysine side-chain deprotection route since polylysine is known to be cytotoxic [19] .
Cleavage of the benzyl protecting group was achieved under basic conditions using 1.5 equivalents of potassium hydroxide in THF per benzyl ester function [20] . After two precipitation steps in diethyl ether and drying under high vacuum, the amphiphilic block copolypeptide product was analyzed by 1 H-NMR spectroscopy in D 2 O. Since the amphiphilic product self-assembles in this medium, it was suggested that the deprotected poly(glutamic acid) (PGA) block would be seen in the spectrum. Indeed, a nearly complete absence of aromatic peaks was observed (Figure 2 ). This indicates that the aromatic rings of carbobenzyloxy protecting groups may be located in the core of micelles and therefore cannot be detected by the magnetic field. The solvent evaporation method was used to obtain self-assembled nanoparticles from PE-b-ZK block copolymers. The polymer was dissolved in THF and the same volume of water was added, followed by evaporation of the THF overnight. In all measurements, 1 mg ml The release profile is shown in Figure 5 . Around 20% burst release of dexamethasone is observed in the first 24 hours, after which the release is steady over the remaining period of the study. After 16 days, 94% of the loaded dexamethasone had been released. 
Conclusions
Well-defined amphiphilic block copolypeptides were prepared by sequential NCA ringopening polymerization and were shown to self-assemble into nanoparticles in aqueous solution at pH 7. The nanoparticle morphology was dependent on composition: spherical micelles were found in the case of the PE 50 -b-ZK 50 polymer, whereas a mixture of spherical 
